Production (Stage)
Kiora Pharmaceuticals, Inc.
KPRX
$3.08
-$0.01-0.32%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -12.05M | 3.59M | 5.55M | 3.20M | 2.81M |
| Total Depreciation and Amortization | 69.10K | 65.70K | -31.20K | -3.00K | 35.80K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.47M | 1.23M | 1.76M | 4.42M | 4.53M |
| Change in Net Operating Assets | 2.74M | 3.67M | 955.90K | -2.83M | -240.90K |
| Cash from Operations | -7.77M | 8.56M | 8.23M | 4.79M | 7.14M |
| Capital Expenditure | -6.30K | -6.30K | -51.30K | -51.30K | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -19.98M | -22.66M | -23.09M | -21.17M | -- |
| Cash from Investing | -19.99M | -22.66M | -23.15M | -21.22M | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 249.40K | 16.69M | 16.70M | 16.70M | 23.12M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 1.10K | -1.19M | -1.69M | -1.69M | -2.42M |
| Cash from Financing | 250.50K | 15.50M | 15.01M | 15.01M | 20.70M |
| Foreign Exchange rate Adjustments | 3.90K | -57.20K | 140.50K | 48.00K | 12.20K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -27.51M | 1.34M | 237.10K | -1.38M | 27.85M |